Medigen Vaccine Biologics Corporation (TPEX: 6547)

Medigen Vaccine Biologics Revenue

Medigen Vaccine Biologics had revenue of 175.22M TWD in the quarter ending June 30, 2024. This brings the company's revenue in the last twelve months to 623.45M, up 2,314.13% year-over-year. In the year 2023, Medigen Vaccine Biologics had annual revenue of 389.62M with 6.73% growth.

• Revenue (ttm): 623.45M
• Revenue Growth: +2,314.13%
• P/S Ratio: 23.27
• Revenue / Employee: 6.05M
• Employees: 103
• Market Cap: 14.51B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	389.62M	24.58M	6.73%
Dec 31, 2022	365.04M	-2.92B	-88.87%
Dec 31, 2021	3.28B	3.27B	28,413.03%
Dec 31, 2020	11.51M	10.39M	927.41%
Dec 31, 2019	1.12M	-	-